Log In
BCIQ
Print this Print this
 

CombiPGS

  Manage Alerts
Collapse Summary General Information
Company CombiMatrix Corp.
DescriptionPreimplantation genetic screening (PGS) test that detects chromosomal abnormalities in embryo cells
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenitourinary, Diagnostic
Indication DetailsIncrease implantation rates and reduce the rate of miscarriage in women undergoing in vitro fertilization (IVF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today